Combination of miristen with tyrosine kinase inhibitor
Important notice: You must inform your CML doctor or a qualified doctor before using this drug. The material presented here is for information purposes only; it is not a substitute for your physician’s guidance and care.
Drug could improve treatment of CML, team says
March 7, 2018, Hematology Times
New Drug Appears Promising Against Chronic Myelogenous Leukemia
March 6, 2018, City of Hope
Bone marrow niche trafficking of miR-126 controls the self-renewal of leukemia stem cells in chronic myelogenous leukemia
March 5, 2018, Nature Medicine